KeyBioscience and Eli Lilly have extended their partnership to develop a new class of treatments for obesity and associated ...

Insitro has signed three strategic agreements with Eli Lilly aimed at advancing treatments for metabolic diseases like MASLD, ...

Eli Lilly and insitro said the deals offers a “new paradigm” for collaborations between major pharmaceutical companies and ...

Companies to extend collaboration on DACRAs with an additional collaboration molecule and investigation of the DACRA platform within multiple indications LUGANO, Switzerland, Oct. 10, 2024 ...